Amgen (AMGN)
(Delayed Data from NSDQ)
$278.39 USD
+1.02 (0.37%)
Updated May 2, 2024 04:00 PM ET
After-Market: $318.00 +39.61 (14.23%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Brokerage Reports
Amgen Inc. [AMGN]
Reports for Purchase
Showing records 221 - 240 ( 427 total )
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Q2 Revenue Flat; KRAS Showing Efficacy in Colorectal Cancer - Hold
Provider: G.RESEARCH, LLC
Analyst: HE J
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN
Provider: Stock Traders Daily